Evidence map›Paper›PMID 42587290›Full record

ArticleBMC biology2026

Peptide language pragmatic analysis and two-stage hierarchical learning framework for therapeutic peptide prediction.

Ke Yan, Siyan Lu, Shutao Chen, Yunjie Wang, Alexey K Shaytan, Zhen Li, Bin Liu

Abstract read
In one paragraph

Article in BMC biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ke YanSchool of Computer Science and Technology, Beijing Institute of Technology, Beijing, 100081, China.
Siyan LuSchool of Computer Science and Technology, Beijing Institute of Technology, Beijing, 100081, China.
Shutao ChenSchool of Computer Science and Technology, Beijing Institute of Technology, Beijing, 100081, China.
Yunjie WangSchool of Computer Science and Technology, Beijing Institute of Technology, Beijing, 100081, China.
Alexey K ShaytanDepartment of Biology, Lomonosov Moscow State University, Moscow, 119234, Russia.
Zhen LiSMBU-MSU-BIT Joint Laboratory On Bioinformatics and Engineering Biology, Shenzhen MSU-BIT University, Shenzhen, Guangdong, 518172, China. lizhen@smbu.edu.cn.
Bin LiuSchool of Computer Science and Technology, Beijing Institute of Technology, Beijing, 100081, China. bliu@bliulab.net.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTherapeutic peptides exert pivotal effects in diverse biological processes, and have attracted significant interest in the field of biomedicine in recent years. However, most existing methods often fail to adequately capture the intricate interactions among amino acid residues and the contextual dependencies within peptide sequences, which hampers the extraction of deep semantic representations and ultimately restricts predictive performance. Moreover, the task of multi-functional therapeutic peptide prediction is inherently constrained by the challenge of imbalanced multi-label classification resulting from long-tailed distribution patterns.

resultsIn this study, we propose a two-stage hierarchical deep learning framework, named TPpred-PepPA, for the prediction of multi-functional therapeutic peptides based on pragmatic analysis. Specifically, ProtT5 is employed to extract deep semantic representations that capture residue-level contextual information. In the first stage, a transformer-based network is utilized to perform shared representation learning, wherein the encoder model captures the intricate inter-residue interaction to characterize the contextual semantics of peptide sequences. In the second stage, the framework is fine-tuned by incorporating task-specific classifiers and optimizing the classification decision with Asymmetric Loss. Then the dynamic thresholding strategy is utilized to address the long-tail distribution problem, enabling more accurate prediction performance of multi-functional therapeutic peptide. Moreover, we adopted the SHAP analysis and motif identification to interpret feature contributions and identify key functional peptide fragments, respectively. Our experimental results indicate that TPpred-PepPA significantly outperforms all current baseline methods in identifying multi-functional therapeutic peptides and exhibits robust performance in recognizing rare functional categories.

conclusionWe developed TPpred-PepPA, a two-stage hierarchical deep learning framework based on the ProtT5 pre-trained large language model. Compared with existing methods, TPpred-PepPA achieves state-of-the-art predictive performance and provides valuable interpretability for the discovery of multi-functional therapeutic peptides. Finally, a web server has been established and is accessible at http://bliulab.net/TPpred-PepPA .

Indexed as

Computational BiologyDeep LearningPeptidesPrediction AlgorithmsPredictive Learning ModelsPeptidesAsymmetric lossLong-tailed distributionMulti-functional therapeutic peptidesProtT5Two-stage deep learning

Identifiers

PMID42587290
PMCPMC13471556

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.